Cargando…
Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459818/ https://www.ncbi.nlm.nih.gov/pubmed/37631317 http://dx.doi.org/10.3390/pharmaceutics15082103 |
_version_ | 1785097503159353344 |
---|---|
author | Dockery, Lance T. Daniel, Marie-Christine |
author_facet | Dockery, Lance T. Daniel, Marie-Christine |
author_sort | Dockery, Lance T. |
collection | PubMed |
description | Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system. |
format | Online Article Text |
id | pubmed-10459818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104598182023-08-27 Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles Dockery, Lance T. Daniel, Marie-Christine Pharmaceutics Article Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system. MDPI 2023-08-09 /pmc/articles/PMC10459818/ /pubmed/37631317 http://dx.doi.org/10.3390/pharmaceutics15082103 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dockery, Lance T. Daniel, Marie-Christine Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title_full | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title_fullStr | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title_full_unstemmed | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title_short | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles |
title_sort | targeted doxorubicin-loaded dendronized gold nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459818/ https://www.ncbi.nlm.nih.gov/pubmed/37631317 http://dx.doi.org/10.3390/pharmaceutics15082103 |
work_keys_str_mv | AT dockerylancet targeteddoxorubicinloadeddendronizedgoldnanoparticles AT danielmariechristine targeteddoxorubicinloadeddendronizedgoldnanoparticles |